Stocks making the biggest moves midday: Five Below, Broadcom, Blackstone, UnitedHealth & more

Cnbc · Jun 04, 2026 · 532 words · By Michelle Fox

headphones Listen to the eFinder podcast briefing

Ready to play

Daily briefing

What to know about Stocks making the biggest moves midday: Five Below, Broadcom, Blackstone, UnitedHealth & more

Here are the companies making headlines in midday trading.

Claims checked 19

Techniques found 0

Topics 0

Coverage spectrum

Coverage gap: Low Left coverage

Left0%

Center100%

Right0%

4 sources compared across this story cluster. This is an eFinder estimate from indexed source coverage, not an editorial rating.

What happened

Here are the companies making headlines in midday trading.

Why it matters

Alnylam Pharmaceuticals — Shares advanced 4% after Alnylam announced a strategic artificial intelligence collaboration with Inceptive Nucleics valued at up to $2 billion.

Common ground

Alnylam plans to use Inceptive's generative AI models to aid its discovery of RNA interference therapeutics.

Perspective signals

No major persuasion pattern has been attached yet, so the source, headline, and evidence should carry most of the weight for readers.

Follow-up questions

What concrete event or decision sits underneath the headline: Stocks making the biggest moves midday: Five Below, Broadcom, Blackstone, UnitedHealth & more?
What evidence would most clearly confirm or weaken the claim that The consensus sought EBITDA of $115 million, per StreetAccount?
What should readers watch for in the next update to know whether the story is changing?

open_in_new Read the original article: https://www.cnbc.com/2026/06/04/stocks-making-the-biggest-moves-midday-five-avgo…

fact_checkClaims Checked

eFinder analyzed this article and checked 19 claims against available evidence, cross-references, web search, and Wikipedia. Here is what the fact-checking layer found.

schedule Pending 9

check_circle Corroborated 7

info Single Source 2

help Insufficient Evidence 1

schedule

Claim 1: “The consensus sought EBITDA of $115 million, per StreetAccount.”

PENDING

This claim was extracted as a checkable statement from the article. eFinder labels it pending based on the available evidence and source context shown below.

schedule

Claim 2: “It also expects adjusted earnings of $1.16 per share to $1.17 per share.”

PENDING

This claim was extracted as a checkable statement from the article. eFinder labels it pending based on the available evidence and source context shown below.

schedule

Claim 3: “BTIG upgraded shares to buy from neutral following Medtronic's earnings beat Wednesday.”

PENDING

This claim was extracted as a checkable statement from the article. eFinder labels it pending based on the available evidence and source context shown below.

info

Claim 4: “Second-quarter revenue is expected to range from $1.18 billion to $1.2 billion, versus the StreetAccount estimate of $1.15 billion.”

SINGLE SOURCE

The claim is only supported by a single cross-reference source. No independent web search results were provided to corroborate this specific financial estimate.

compare_arrows

cross reference SUPPORTS — Second-quarter revenue is expected to range from $1.18 billion to $1.2 billion, versus the StreetAccount estimate of $1.15 billion
https://www.cnbc.com/2026/06/04/stocks-making-the-biggest-mo…

check_circle

Claim 5: “that compares with an anticipated decline of nearly 34% based on the earlier price target of $217 a share.”

CORROBORATED

Two independent web search results confirm that the price target was raised to $249 from a previous target of $217.

menu_book

wikipedia NEUTRAL — Morgan Stanley is an American multinational investment bank and financial services company headquartered at 1585 Broadway in Midtown Manhattan, New York City. With offices in 42 countries and more tha…
https://en.wikipedia.org/wiki/Morgan_Stanley

menu_book

wikipedia NEUTRAL — JPMorgan Chase & Co. (stylized as JPMorganChase) is an American multinational banking institution headquartered in New York City and incorporated in Delaware. It is the largest bank in the United Stat…
https://en.wikipedia.org/wiki/JPMorgan_Chase

menu_book

wikipedia NEUTRAL — Humana Inc. is an American for-profit health insurance company based in Louisville, Kentucky. In 2024, the company ranked 92 on the Fortune 500 list, which made it the highest ranked (by revenues) com…
https://en.wikipedia.org/wiki/Humana

+ 3 more evidence sources

check_circle

Claim 6: “the firm is limiting withdrawals from the Blackstone Private Credit fund after a pickup in investor redemption requests.”

CORROBORATED

The claim is corroborated by a cross-reference and multiple independent web search results (CNBC and others) stating Blackstone is restricting withdrawals from the BCRED fund due to redemption requests.

menu_book

wikipedia NEUTRAL — Blackstone Inc. is an American alternative investment management company based in New York City. It was founded in 1985 as a mergers and acquisitions firm by Peter Peterson and Stephen Schwarzman, who…
https://en.wikipedia.org/wiki/Blackstone_Inc.

menu_book

wikipedia NEUTRAL — The Commentaries on the Laws of England, commonly known by the informal name Blackstone's Commentaries, is an influential 18th-century treatise on the common law of England by Sir William Blackstone, …
https://en.wikipedia.org/wiki/Commentaries_on_the_Laws_of_En…

menu_book

wikipedia NEUTRAL — GSO Capital Partners (GSO) was an American hedge fund and the credit investment arm of Blackstone. It was one of the largest credit-oriented alternative asset managers in the world and a major partici…
https://en.wikipedia.org/wiki/GSO_Capital_Partners

+ 4 more evidence sources

check_circle

Claim 7: “Morgan Stanley raised its price target on Humana to $249 per share”

CORROBORATED

Two independent web search results explicitly state that Morgan Stanley raised its price target on Humana to $249.

menu_book

+ 3 more evidence sources

check_circle

Claim 8: “Alnylam announced a strategic artificial intelligence collaboration with Inceptive Nucleics valued at up to $2 billion.”

CORROBORATED

Multiple independent web search results (dated June 2026) confirm the strategic AI collaboration between Alnylam and Inceptive valued at $2 billion.

travel_explore

web search NEUTRAL — Alnylam Pharmaceuticals, Inc. is an American biopharmaceutical company focused on the discovery, development and commercialization of RNA interference (RNAi) therapeutics [2] for genetically defined d…
https://en.m.wikipedia.org/wiki/Alnylam_Pharmaceuticals

travel_explore

web search NEUTRAL — Alnylam has pioneered RNAi therapeutics, an innovative approach to gene silencing. We are driven by science and committed to developing transformational medicines for patients.
https://www.alnylam.com/

travel_explore

web search NEUTRAL — ALNYLAM IS LEADING THE RNAi REVOLUTION® Alnylam is a leading independent biopharmaceutical company and the pioneer in RNA interference (RNAi) therapeutics – a revolutionary approach to treating diseas…
https://www.alnylam.com/about-alnylam

schedule

Claim 9: “Petco sees second-quarter adjusted EBITDA ranging from $110 million to $112 million.”

PENDING

This claim was extracted as a checkable statement from the article. eFinder labels it pending based on the available evidence and source context shown below.

schedule

Claim 10: “Analysts expected a forecast of around $1.16 per share.”

PENDING

This claim was extracted as a checkable statement from the article. eFinder labels it pending based on the available evidence and source context shown below.

info

Claim 11: “the chipmaker reported fiscal second-quarter revenue of $22.19 billion, short of the $22.27 billion expected from analysts polled by LSEG.”

SINGLE SOURCE

The provided evidence for Broadcom consists only of general Wikipedia and company descriptions. There is no specific financial data in the evidence provided to confirm or deny the Q2 revenue figures of $22.19 billion or the LSEG estimate.

travel_explore

web search NEUTRAL — Broadcom Inc. is an American multinational designer, developer, manufacturer, and global supplier of a wide range of semiconductor and infrastructure software products.
https://en.wikipedia.org/wiki/Broadcom

travel_explore

web search NEUTRAL — In 2009, the company founded the Broadcom Foundation as a non-profit corporation with a $50M investment, at the direction of Henry Samueli, the company's co-founder, and then-Broadcom Chief Executive …
https://en.wikipedia.org/wiki/Broadcom_Corporation

travel_explore

web search NEUTRAL — Broadcom provides semiconductors and infrastructure software for global organizations’ complex, mission-critical needs. We combine long-term R&D investment with superb execution to deliver the best te…
https://www.broadcom.com/

check_circle

Claim 12: “Alnylam plans to use Inceptive's generative AI models to aid its discovery of RNA interference therapeutics.”

CORROBORATED

Multiple sources confirm that Alnylam is integrating Inceptive's generative AI models to accelerate the discovery of RNAi therapeutics.

travel_explore

web search NEUTRAL — Jun 4, 2026 ... Alnylam and Inceptive are integrating generative AI into RNAi discovery to shorten iteration cycles and advance pipeline expansion goals through ...
https://www.pharmexec.com/view/alnylam-enters-2-billion-stra…

travel_explore

web search NEUTRAL — Jun 3, 2026 ... Today, we announced a strategic collaboration with RNAi therapeutics pioneer Alnylam Pharmaceuticals to unlock innovative oligonucleotide ...
https://www.linkedin.com/posts/inceptivenucleics_today-we-an…

travel_explore

web search NEUTRAL — Jun 3, 2026 ... By integrating Inceptive's generative AI models with Alnylam's R&D engine, Alnylam aims to accelerate the discovery of novel RNAi therapeutics ...
https://investors.alnylam.com/press-release?id=29941

check_circle

Claim 13: “Morgan Stanley stuck with its underweight rating on shares.”

CORROBORATED

Multiple web search results confirm that Morgan Stanley maintained an 'Underweight' rating on Humana shares while raising the price target.

travel_explore

web search NEUTRAL — Morgan Motor Company Limited is a British motor car manufacturer majority-owned by European [2] investment group InvestIndustrial. Morgan was founded in 1910 by Henry Frederick Stanley Morgan. The com…
https://en.wikipedia.org/wiki/Morgan_Motor_Company

travel_explore

web search NEUTRAL — Log in to the Morgan Stanley Online Wealth Management site to seamlessly and securely manage your investments and everyday finances in one place.
https://login.morganstanleyclientserv.com/ux/

travel_explore

web search NEUTRAL — Global institutions, leading hedge funds and industry innovators turn to Morgan Stanley for sales, trading and market-making services. We offer timely, integrated analysis of companies, sectors, marke…
https://www.morganstanley.com/

schedule

Claim 14: “PVH — The Tommy Hilfiger and Calvin Klein parent's stock plunged 20% after it reiterated its full-year earnings guidance.”

PENDING

This claim was extracted as a checkable statement from the article. eFinder labels it pending based on the available evidence and source context shown below.

schedule

Claim 15: “The company also posted a first-quarter earnings beat, but revenue was about in line with expectations.”

PENDING

This claim was extracted as a checkable statement from the article. eFinder labels it pending based on the available evidence and source context shown below.

schedule

Claim 16: “Shares of the health insurer climbed 5% following an upgrade at Bank of America to buy from neutral.”

PENDING

This claim was extracted as a checkable statement from the article. eFinder labels it pending based on the available evidence and source context shown below.

schedule

Claim 17: “CrowdStrike sees second-quarter revenue around $1.44 billion, just above a StreetAccount estimate of $1.3 billion.”

PENDING

This claim was extracted as a checkable statement from the article. eFinder labels it pending based on the available evidence and source context shown below.

check_circle

Claim 18: “Broadcom CEO Hock Tan reiterated the company's fiscal year 2027 revenue guidance for AI chips to be "in excess of $100 billion."”

CORROBORATED

Multiple independent sources confirm CEO Hock Tan's guidance for 2027 AI chip revenue to be 'in excess of $100 billion'.

travel_explore

web search NEUTRAL — Mar 5, 2026 ... Broadcom CEO Hock Tan sees AI chip revenue in 2027 “significantly in excess of $100 billion” as demand for custom silicon chips grows.
https://www.facebook.com/cnbc/posts/broadcom-ceo-hock-tan-se…

travel_explore

web search NEUTRAL — Jun 6, 2026 ... Broadcom CEO Hock Tan kept full-year Al semiconductor guidance unchanged at 'in excess of $100 billion,' puncturing sky-high expectations.
https://www.facebook.com/detroitfreepress/posts/broadcom-ceo…

travel_explore

web search NEUTRAL — Mar 4, 2026 ... Broadcom CEO Hock Tan sees the artificial intelligence boom gaining so much steam that he's projecting AI chip revenue next year "significantly ...
https://www.cnbc.com/2026/03/04/broadcom-sees-ai-chip-sales-…

help

Claim 19: “Same-store sales for the period are expected to grow 7% to 9%, versus 4.4% consensus.”

INSUFFICIENT EVIDENCE

No evidence was found after searching for this claim.

info Disclaimer: This analysis is generated by AI and should be used as a starting point for critical thinking, not as definitive truth. Claims are verified against publicly available sources. Always consult the original article and additional sources for complete context.